Kiora Pharmaceuticals, Inc. (KPRX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | -100% | - | - | - | - | - | - | - | - | - | - | - | - | -100% | - | - |
| Cost of Goods Sold | 41.98K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.93K | 0 | 0 | 0 | 10.29K | 0 | 0 | 0 | 59.5K | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -41.98K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16M | -7.93K | 0 | 0 | 0 | -10.29K | 0 | 0 | 0 | -59.5K | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | -100% | 100% | - | - | - | 22.85% | - | - | - | 82.71% | - | - | - | 91.57% | - | - |
| Operating Expenses | 2.46M | 7.31M | 794.44K | 2.4M | 2.33M | 2.56M | 3.6M | 2.54M | 2.78M | 1.98M | 5.92M | 2.63M | 1.92M | 2.65M | 3.7M | 2.4M | 3.57M | 2.23M | 3.04M | 2.82M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | 17.36% | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.61M | 1.46M | 1.44M | 1.35M | 1.49M | 1.33M | 1.38M | 1.54M | 1.3M | 872.62K | 1.42M | 1.1M | 1.27M | 1.8M | 2.03M | 1.8M | 1.66M | 1.23M | 1.34M | 1.31M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | 8.1% | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 2.12M | 1.17M | 1.07M | 904.57K | 565.76K | 1.18M | 1.32M | 906.68K | 1.68M | 1.11M | 1.09M | 1.39M | 438.28K | 841.62K | 1.33M | 567.23K | 707.93K | 1M | 1.63M | 1.44M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | 10.53% | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -1000K | 1000K | -1000K | 137.78K | 275.19K | 58.48K | 904.01K | 100.23K | -202.75K | 0 | 1000K | 143.62K | 208.93K | 0 | 337.51K | 32.94K | 1000K | 0 | 68.01K | 73.72K |
| Operating Income | -2.5M | -7.31M | -794.44K | -2.4M | -2.33M | -2.56M | -3.6M | -2.54M | 13.22M | -1.99M | -5.92M | -2.63M | -1.92M | -2.66M | -3.7M | -2.4M | -3.57M | -2.29M | -3.04M | -2.82M |
| Operating Margin % | - | - | - | - | - | - | - | - | 82.64% | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -7.4% | -185.03% | 77.95% | 5.84% | -117.62% | -28.74% | 39.14% | 3.35% | 789.85% | 25.01% | -59.83% | -9.62% | 46.3% | -15.98% | -22.01% | 14.81% | -77.57% | -95.85% | -51.21% | -63.79% |
| EBITDA | -2.46M | -7.3M | -783.88K | -2.39M | -2.33M | -2.56M | -3.6M | -2.54M | 13.23M | -1.98M | -5.91M | -2.61M | -1.91M | -2.65M | -3.69M | -2.39M | -3.56M | -2.23M | -3.02M | -2.81M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | 82.67% | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -5.61% | -185.28% | 78.23% | 5.74% | -117.62% | -28.95% | 39.06% | 2.76% | 793.75% | 25.02% | -59.97% | -9.15% | 46.42% | -18.61% | -22.11% | 14.79% | -77.97% | -92.25% | -51.31% | -63.88% |
| D&A (Non-Cash Add-back) | 41.98K | 10.51K | 10.55K | 3.42K | 318 | 5.91K | 2.1K | 6.33K | 4.87K | 7.93K | 11.31K | 22.48K | 10.08K | 10.29K | 10.27K | 10.28K | 10.77K | 59.5K | 11.06K | 12.6K |
| EBIT | -2.5M | -5.27M | -2.52M | -2.26M | -2.06M | -2.41M | -2.7M | -2.42M | 13.21M | -2.18M | -2.5M | -2.49M | -1.71M | -2.61M | -3.37M | -2.37M | -2.37M | -5.94M | -2.97M | -2.54M |
| Net Interest Income | 139.34K | 190.31K | 201.82K | 225.24K | 276.63K | 417.41K | 248.84K | 342.1K | 223.05K | 45.52K | 49.91K | 45.09K | 33.47K | 38.98K | 7.86K | 1.24K | 217 | -3.83K | 259 | -1.7K |
| Interest Income | 139.34K | 190.31K | 201.82K | 225.24K | 276.63K | 438.86K | 248.84K | 342.1K | 223.05K | 45.52K | 49.91K | 45.09K | 33.47K | 38.98K | 7.86K | 1.24K | 217 | 300 | 259 | 332 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 21.45K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.13K | 0 | 2.03K |
| Other Income/Expense | 84.78K | 143.59K | 178.11K | 131.68K | 260.38K | 406.19K | 188.91K | 323.24K | 231.11K | -186.09K | 155.63K | 19.2K | 48.13K | 45.28K | -1.42M | 1.24K | 4.43K | -3.66M | 259 | 276.49K |
| Pretax Income | -2.42M | -7.17M | -616.32K | -2.26M | -2.07M | -2.16M | -3.41M | -2.22M | 13.45M | -2.18M | -5.76M | -2.61M | -1.87M | -2.61M | -5.12M | -2.4M | -3.57M | -5.95M | -3.03M | -2.54M |
| Pretax Margin % | - | - | - | - | - | - | - | - | 84.08% | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | -649.97K | -643.13K | -112.06K | 123.01K | 2.07M | 0 | 0 | 0 | 90.32K | 0 | 0 | 0 | -113.01K | 0 | 0 | 0 | -192.6K | 0 | 0 |
| Effective Tax Rate % | 0% | 9.07% | 104.35% | 4.95% | -5.94% | -95.67% | 0% | 0% | 0% | -4.15% | 0% | 0% | 0% | 4.33% | 0% | 0% | 0% | 3.24% | 0% | 0% |
| Net Income | -2.42M | -6.52M | 26.81K | -2.15M | -2.19M | -4.22M | -3.41M | -2.22M | 13.45M | -2.27M | -5.76M | -2.61M | -1.87M | -2.5M | -5.12M | -2.4M | -3.57M | -5.75M | -3.03M | -2.54M |
| Net Margin % | - | - | - | - | - | - | - | - | 84.08% | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -10.26% | -54.29% | 100.79% | 3.11% | -116.3% | -86.17% | 40.77% | 15% | 819.99% | 9.2% | -12.57% | -8.87% | 47.59% | 56.58% | -68.69% | 5.59% | -77.31% | -385.3% | -51.22% | -48.1% |
| Net Income (Continuing) | -2.42M | -6.52M | 26.81K | -2.15M | -2.19M | -4.22M | -3.41M | -2.22M | 13.45M | -2.27M | -5.76M | -2.61M | -1.87M | -2.5M | -5.12M | -2.4M | -3.57M | -5.75M | -3.03M | -2.54M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.58 | -1.59 | 0.01 | -0.54 | -0.52 | -1.41 | -0.81 | -0.53 | 3.46 | -0.29 | -0.81 | -0.79 | -1.20 | -1.52 | -7.70 | -7.35 | -10.91 | -32.65 | -11.09 | -13.23 |
| EPS Growth % | -11.54% | -12.77% | 100.77% | -1.89% | -115.03% | -386.21% | 0% | 32.91% | 388.33% | 80.92% | 89.48% | 89.25% | 89% | 95.34% | 30.57% | 44.44% | 22.24% | -53.65% | 37.17% | 12.56% |
| EPS (Basic) | -0.58 | -1.55 | 0.01 | -0.54 | -0.52 | -1.41 | -0.81 | -0.53 | 4.67 | -0.29 | -0.81 | -0.79 | -1.20 | -1.52 | -7.70 | -7.35 | -11.25 | -32.65 | -11.56 | -13.23 |
| Diluted Shares Outstanding | 4.17M | 4.1M | 4.36M | 3.99M | 4.22M | 3M | 4.21M | 4.17M | 35.03M | 7.71M | 7.11M | 3.29M | 1.86M | 1.8M | 848.53K | 326.64K | 326.46K | 256.63K | 267.59K | 186.66K |
| Basic Shares Outstanding | 4.17M | 4.17M | 4.29M | 3.99M | 4.22M | 3M | 4.21M | 4.17M | 25.94M | 7.71M | 7.11M | 3.29M | 1.86M | 1.8M | 848.53K | 326.64K | 316.38K | 256.63K | 256.63K | 186.66K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |